|
|
|
Insider
Information: |
Rhodes Jason P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
138,000 |
|
Indirect Shares
|
23,308,240 |
|
|
Direct
Value |
$202,860 |
|
|
Indirect Value
|
$404,071,929 |
|
|
Total
Shares |
23,446,240 |
|
|
Total
Value |
$404,274,789 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-2.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Epizyme, Inc. |
EPZM |
President, CFO and Tre... |
2014-09-22 |
138,000 |
2014-01-06 |
0 |
Premium* |
|
Replimune Group Inc |
REPL |
Director |
2018-07-24 |
0 |
2021-01-26 |
3,228,912 |
Premium* |
|
Generation Bio Co. |
GBIO |
Director |
|
0 |
2021-09-29 |
8,279,484 |
Premium* |
|
Dyne Therapeutics, Inc. |
DYN |
|
|
0 |
2024-03-01 |
6,545,479 |
Premium* |
|
Disc Medicine, Inc |
IRON |
Director |
|
0 |
2021-02-05 |
5,254,365 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REPL |
Replimune Group Inc |
Director |
|
2020-12-07 |
4 |
AS |
$45.45 |
$3,120,459 |
I/I |
(67,890) |
35,709 |
0 |
% |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-05-05 |
4 |
AS |
$21.53 |
$645,840 |
D/D |
(30,000) |
46,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-06-02 |
4 |
AS |
$22.14 |
$665,870 |
D/D |
(30,000) |
58,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-04-07 |
4 |
OE |
$0.51 |
$17,850 |
D/D |
35,000 |
59,000 |
0 |
- |
|
GBIO |
Generation Bio Co. |
Director |
|
2021-04-12 |
4 |
AS |
$26.07 |
$1,938,229 |
I/I |
(74,124) |
66,558 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-07-07 |
4 |
AS |
$32.52 |
$982,161 |
D/D |
(30,000) |
70,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-02-10 |
4 |
OE |
$0.51 |
$187,200 |
D/D |
70,000 |
74,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-05-05 |
4 |
OE |
$0.51 |
$133,530 |
D/D |
42,000 |
76,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-08-04 |
4 |
AS |
$29.26 |
$892,324 |
D/D |
(30,000) |
82,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-06-02 |
4 |
OE |
$0.51 |
$66,870 |
D/D |
42,000 |
88,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-09-02 |
4 |
AS |
$33.37 |
$1,004,163 |
D/D |
(30,000) |
94,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-07-07 |
4 |
OE |
$0.51 |
$39,960 |
D/D |
42,000 |
100,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-08-04 |
4 |
OE |
$0.60 |
$48,720 |
D/D |
42,000 |
112,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-09-02 |
4 |
OE |
$0.60 |
$42,840 |
D/D |
42,000 |
124,000 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
|
2014-09-22 |
4 |
OE |
$0.51 |
$22,440 |
D/D |
44,000 |
138,000 |
0 |
- |
|
GBIO |
Generation Bio Co. |
Director |
|
2021-04-09 |
4 |
AS |
$27.57 |
$1,205,948 |
I/I |
(43,681) |
140,682 |
0 |
- |
|
GBIO |
Generation Bio Co. |
Director |
|
2021-04-08 |
4 |
AS |
$28.47 |
$1,241,241 |
I/I |
(43,550) |
184,363 |
0 |
- |
|
GBIO |
Generation Bio Co. |
Director |
|
2021-04-07 |
4 |
AS |
$28.48 |
$1,136,671 |
I/I |
(39,864) |
227,913 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-03-01 |
4 |
AS |
$30.05 |
$1,398,347 |
I/I |
(46,534) |
847,388 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-28 |
4 |
AS |
$24.83 |
$4,741,804 |
I/I |
(190,920) |
864,487 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-27 |
4 |
AS |
$24.38 |
$8,998,426 |
I/I |
(368,699) |
877,806 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-26 |
4 |
AS |
$23.59 |
$5,886,673 |
I/I |
(248,219) |
903,527 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-23 |
4 |
AS |
$22.70 |
$4,470,266 |
I/I |
(196,928) |
920,843 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
Director |
|
2022-12-12 |
4 |
B |
$10.70 |
$10,000,017 |
I/I |
934,581 |
934,581 |
2.1 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2021-01-26 |
4 |
AS |
$46.14 |
$256,446 |
I/I |
(5,558) |
946,000 |
0 |
% |
|
62 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|